ACW 4.05% 7.1¢ actinogen medical limited

Ann: Appendix 4E & Financial Statements, page-3

  1. 1 Posts.
    "In September 2016, an update research report was published by Baker Young on Actinogen Medical entitled: Actinogen Medical – Best Risk vs Reward Play in Alzheimer’s Dementia. This report details the investment opportunity presented by ACW, with Baker Young estimating Actinogen Medical’s target share price at $0.39, against the current share price of around $0.06."

    I don't think the market has taken much note of Baker Young's research...
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.003(4.05%)
Mkt cap ! $191.2M
Open High Low Value Volume
7.3¢ 7.9¢ 6.9¢ $1.067M 14.27M

Buyers (Bids)

No. Vol. Price($)
1 307386 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 76342 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.